Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for ICLR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 235.34M
March 31, 2026 136.24M
December 31, 2025 170.17M
September 30, 2025 352.22M
June 30, 2025 127.27M
March 31, 2025 239.33M
December 31, 2024 252.43M
September 30, 2024 370.33M
June 30, 2024 180.40M
March 31, 2024 299.92M
December 31, 2023 377.79M
September 30, 2023 314.37M
June 30, 2023 174.04M
March 31, 2023 148.76M
December 31, 2022 -97.77M
September 30, 2022 154.67M
June 30, 2022 144.57M
March 31, 2022 207.28M
December 31, 2021 226.36M
September 30, 2021 236.65M
June 30, 2021 115.59M
March 31, 2021 103.22M
December 31, 2020 180.17M
September 30, 2020 119.43M
June 30, 2020 107.99M
Date Value
March 31, 2020 131.45M
December 31, 2019 114.64M
September 30, 2019 144.71M
June 30, 2019 11.04M
March 31, 2019 87.60M
December 31, 2018 37.24M
September 30, 2018 114.30M
June 30, 2018 29.35M
March 31, 2018 31.34M
December 31, 2017 84.06M
September 30, 2017 113.33M
June 30, 2017 4.767M
March 31, 2017 151.03M
December 31, 2016 111.32M
September 30, 2016 42.37M
June 30, 2016 5.658M
March 31, 2016 51.66M
December 31, 2015 99.64M
September 30, 2015 62.07M
June 30, 2015 14.68M
March 31, 2015 50.42M
December 31, 2014 57.05M
September 30, 2014 101.35M
June 30, 2014 -61.72M
March 31, 2014 32.50M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
IQVIA Holdings, Inc. 360.00M
Medpace Holdings, Inc. 138.10M
Proteome Sciences Plc --
Champions Oncology, Inc. -2.237M
Avantor, Inc. 140.60M